loadpatents
Patent applications and USPTO patent grants for Hartman; George D..The latest application filed is for "oxadiazepinone derivatives and methods of treating hepatitis b infections".
Patent | Date |
---|---|
Oxadiazepinone Derivatives And Methods Of Treating Hepatitis B Infections App 20210252014 - Kuduk; Scott ;   et al. | 2021-08-19 |
Diazepinone Derivatives And Their Use In The Treatment Of Hepatitis B Infections App 20210188849 - Kuduk; Scott ;   et al. | 2021-06-24 |
Oxadiazepinone derivatives and methods of treating hepatitis B infections Grant 10,987,359 - Kuduk , et al. April 27, 2 | 2021-04-27 |
Diazepinone derivatives and their use in the treatment of hepatitis B infections Grant 10,975,077 - Kuduk , et al. April 13, 2 | 2021-04-13 |
Oxadiazepinone Derivatives And Methods Of Treating Hepatitis B Infections App 20200197408 - Kuduk; Scott ;   et al. | 2020-06-25 |
Diazepinone Derivatives And Their Use In The Treatment Of Hepatitis B Infections App 20200181144 - Kuduk; Scott ;   et al. | 2020-06-11 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20200181142 - Hartman; George D. ;   et al. | 2020-06-11 |
Combination therapy for treatment of HBV infections Grant 10,632,112 - Hartman | 2020-04-28 |
Derivatives and methods of treating hepatitis B infections Grant 10,556,904 - Hartman , et al. Feb | 2020-02-11 |
Derivatives and methods of treating hepatitis B infections Grant 10,544,141 - Hartman , et al. Ja | 2020-01-28 |
Azocane and azonane derivatives and methods of treating hepatitis B infections Grant 10,537,580 - Hartman , et al. Ja | 2020-01-21 |
Derivatives and methods of treating hepatitis B infections Grant 10,538,519 - Hartman , et al. Ja | 2020-01-21 |
Azepane derivatives and methods of treating hepatitis B infections Grant 10,392,349 - Hartman , et al. A | 2019-08-27 |
Metabolic Restriction In Cell-based Assays App 20190234940 - LAM; Man Iu ;   et al. | 2019-08-01 |
Azepane derivatives and methods of treating hepatitis B infections Grant 10,364,228 - Hartman | 2019-07-30 |
Combination Therapy For Treatment Of Hbv Infections App 20190209541 - Hartman; George D. | 2019-07-11 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190194191 - Hartman; George D. ;   et al. | 2019-06-27 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190077800 - Hartman; George D. ;   et al. | 2019-03-14 |
Combination therapy for treatment of HBV infections Grant 10,213,420 - Hartman Feb | 2019-02-26 |
Hepatitis B antiviral agents Grant 10,196,376 - Hartman , et al. Fe | 2019-02-05 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190031653 - Hartman; George D. ;   et al. | 2019-01-31 |
Derivatives and methods of treating hepatitis B infections Grant 10,189,835 - Hartman , et al. Ja | 2019-01-29 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20190016682 - Hartman; George D. ;   et al. | 2019-01-17 |
Derivatives and methods of treating hepatitis B infections Grant 10,093,669 - Hartman , et al. October 9, 2 | 2018-10-09 |
Crystalline forms of a hepatitis B antiviral agent Grant 10,077,239 - Hartman September 18, 2 | 2018-09-18 |
Derivatives and methods of treating hepatitis B infections Grant 10,077,264 - Hartman , et al. September 18, 2 | 2018-09-18 |
Azocane And Azonane Derivatives And Methods Of Treating Hepatitis B Infections App 20180201590 - Hartman; George D. ;   et al. | 2018-07-19 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20180127415 - Hartman; George D. ;   et al. | 2018-05-10 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20180044300 - Hartman; George D. | 2018-02-15 |
Derivatives and methods of treating hepatitis B infections Grant 9,890,161 - Hartman , et al. February 13, 2 | 2018-02-13 |
Azocane and azonane derivatives and methods of treating hepatitis B infections Grant 9,884,831 - Hartman , et al. February 6, 2 | 2018-02-06 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,873,671 - Hartman , et al. January 23, 2 | 2018-01-23 |
Hepatitis B Antiviral Agents App 20170334882 - Hartman; George D. ;   et al. | 2017-11-23 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,758,489 - Hartman September 12, 2 | 2017-09-12 |
Hepatitis B antiviral agents Grant 9,751,857 - Hartman , et al. September 5, 2 | 2017-09-05 |
Combination Therapy For Treatment Of Hbv Infections App 20170182021 - Hartman; George D. | 2017-06-29 |
Hepatitis B antiviral agents Grant 9,676,747 - Hartman , et al. June 13, 2 | 2017-06-13 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170158691 - Hartman; George D. ;   et al. | 2017-06-08 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170121328 - Hartman; George D. ;   et al. | 2017-05-04 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170121329 - Hartman; George D. ;   et al. | 2017-05-04 |
Crystalline Forms Of A Hepatitis B Antiviral Agent App 20170114018 - Hartman; George D. | 2017-04-27 |
Hepatitis B antiviral agents Grant 9,579,313 - Hartman February 28, 2 | 2017-02-28 |
Derivatives and methods of treating hepatitis B infections Grant 9,550,779 - Hartman , et al. January 24, 2 | 2017-01-24 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20170015629 - Hartman; George D. ;   et al. | 2017-01-19 |
Derivatives and methods of treating hepatitis B infections Grant 9,527,845 - Hartman , et al. December 27, 2 | 2016-12-27 |
Derivatives and methods of treating hepatitis B infections Grant 9,518,057 - Hartman , et al. December 13, 2 | 2016-12-13 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,505,722 - Hartman , et al. November 29, 2 | 2016-11-29 |
Azocane And Azonane Derivatives And Methods Of Treating Hepatitis B Infections App 20160272599 - Hartman; George D. ;   et al. | 2016-09-22 |
Piperidine derivatives and methods of treating hepatitis B infections Grant 9,400,280 - Hartman July 26, 2 | 2016-07-26 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185777 - Hartman; George D. ;   et al. | 2016-06-30 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185779 - Hartman; George D. ;   et al. | 2016-06-30 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185778 - Hartman; George D. ;   et al. | 2016-06-30 |
Hepatitis B Antiviral Agents App 20160158214 - Hartman; George D. | 2016-06-09 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,339,510 - Hartman , et al. May 17, 2 | 2016-05-17 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20160000812 - Hartman; George D. ;   et al. | 2016-01-07 |
Hepatitis B antiviral agents Grant 9,205,079 - Hartman December 8, 2 | 2015-12-08 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,181,288 - Hartman , et al. November 10, 2 | 2015-11-10 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150315159 - Hartman; George D. | 2015-11-05 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,169,212 - Hartman , et al. October 27, 2 | 2015-10-27 |
Piperidine Derivatives And Methods Of Treating Hepatitis B Infections App 20150274652 - Hartman; George D. | 2015-10-01 |
Hepatitis B Antiviral Agents App 20150259324 - Hartman; George D. ;   et al. | 2015-09-17 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,115,113 - Hartman August 25, 2 | 2015-08-25 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150225355 - Hartman; George D. | 2015-08-13 |
Combination Therapy For Treatment Of Hbv Infections App 20150216938 - Hartman; George D. | 2015-08-06 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150197493 - Hartman; George D. | 2015-07-16 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150197533 - Hartman; George D. ;   et al. | 2015-07-16 |
Hepatitis B antiviral agents Grant 9,066,932 - Hartman , et al. June 30, 2 | 2015-06-30 |
Hepatitis B Antiviral Agents App 20150174115 - Hartman; George D. | 2015-06-25 |
Hepatitis B antiviral agents Grant 9,061,008 - Hartman , et al. June 23, 2 | 2015-06-23 |
Hepatitis B Antiviral Agents App 20150152073 - Hartman; George D. ;   et al. | 2015-06-04 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150132258 - Hartman; George D. | 2015-05-14 |
Hepatitis B antiviral agents Grant 8,993,771 - Hartman March 31, 2 | 2015-03-31 |
Hepatitis B Antiviral Agents App 20140275167 - Hartman; George D. | 2014-09-18 |
Hepatitis B Antiviral Agents App 20140178337 - Hartman; George D. ;   et al. | 2014-06-26 |
Hepatitis B Antiviral Agents App 20140179665 - Hartman; George D. ;   et al. | 2014-06-26 |
Hepatitis B antiviral agents Grant 8,629,274 - Hartman , et al. January 14, 2 | 2014-01-14 |
Hepatitis B Antiviral Agents App 20130251673 - HARTMAN; George D. ;   et al. | 2013-09-26 |
Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids App 20110224447 - Bowman; Keith A. ;   et al. | 2011-09-15 |
Heteroaryl piperidine glycine transporter inhibitors Grant 7,825,135 - Blackaby , et al. November 2, 2 | 2010-11-02 |
Mitotic kinesin inhibitors Grant 7,745,639 - Breslin , et al. June 29, 2 | 2010-06-29 |
Mitotic kinesin inhibitors Grant 7,732,472 - Fraley , et al. June 8, 2 | 2010-06-08 |
Prodrugs of mitotic kinesin inhibitors Grant 7,718,687 - Coleman , et al. May 18, 2 | 2010-05-18 |
Mitotic kinesin inhibitors Grant 7,632,833 - Bergman , et al. December 15, 2 | 2009-12-15 |
Mitotic kinesin inhibitors Grant 7,632,839 - Coleman , et al. December 15, 2 | 2009-12-15 |
Mitotic kinesin inhibitors Grant 7,625,912 - Arrington , et al. December 1, 2 | 2009-12-01 |
Mitotic kinesin inhibitors Grant 7,625,936 - Coleman , et al. December 1, 2 | 2009-12-01 |
Mitotic kinesin inhibitors Grant 7,618,971 - Coleman , et al. November 17, 2 | 2009-11-17 |
Inhibitors of Checkpoint Kinases App 20090258852 - Arrington; Kenneth L. ;   et al. | 2009-10-15 |
Mitotic kinesin inhibitors Grant 7,553,838 - Fraley , et al. June 30, 2 | 2009-06-30 |
Mitotic Kinesin Inhibitors App 20090124641 - Coleman; Paul J. ;   et al. | 2009-05-14 |
Proline bis-amide orexin receptor antagonists App 20090118200 - Bergman; Jeffrey M. ;   et al. | 2009-05-07 |
Mitotic Kinesin Inhibitors App 20090005418 - Fraley; Mark E. ;   et al. | 2009-01-01 |
Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP Grant 7,465,746 - Coleman , et al. December 16, 2 | 2008-12-16 |
Mitotic Kinesin Inhibitors App 20080287414 - Bergman; Jeffrey M. ;   et al. | 2008-11-20 |
Tyrosine kinase inhibitors App 20080274107 - Fraley; Mark E. ;   et al. | 2008-11-06 |
Mitotic Kinesin Inhibitors App 20080207693 - Coleman; Paul J. ;   et al. | 2008-08-28 |
Mitotic Kinesin Inhibitors App 20080194582 - Coleman; Paul J. ;   et al. | 2008-08-14 |
Mitotic Kinesin Inhibitors App 20080139586 - Coleman; Paul J. ;   et al. | 2008-06-12 |
Substituted thienopyrimidinones as a mitotic kinesin inhibitor Grant 7,378,411 - Fraley , et al. May 27, 2 | 2008-05-27 |
Mitotic Kinesin Inhibitors App 20080102068 - Coleman; Paul J. ;   et al. | 2008-05-01 |
Mitotic kinesin inhibitors Grant 7,348,440 - Arrington , et al. March 25, 2 | 2008-03-25 |
Prodrugs of mitotic kinesin inhibitors Grant 7,329,762 - Fraley , et al. February 12, 2 | 2008-02-12 |
Mitotic Kinesin Inhibitors App 20080032980 - Fraley; Mark E. ;   et al. | 2008-02-07 |
Prodrugs Of Mitotic Kinesin Inhibitors App 20080027118 - Coleman; Paul J. ;   et al. | 2008-01-31 |
Mitotic Kinesin Inhibitors App 20080027058 - Coleman; Paul J. ;   et al. | 2008-01-31 |
Heteroaryl Piperidine Glycine Transporter Inhibitors App 20070254880 - Blackaby; Wesley ;   et al. | 2007-11-01 |
Tyrosine kinase inhibitors Grant 7,265,134 - Hartman , et al. September 4, 2 | 2007-09-04 |
Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor Grant 7,262,187 - Fraley , et al. August 28, 2 | 2007-08-28 |
Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor Grant 7,262,186 - Fraley , et al. August 28, 2 | 2007-08-28 |
Substituted furopyrimidinones as a mitotic kinesin inhibitors Grant 7,244,723 - Fraley , et al. July 17, 2 | 2007-07-17 |
Mitotic kinesin inhibitors App 20070149553 - Arrington; Kenneth L. ;   et al. | 2007-06-28 |
Mitotic kinesin inhibitors Grant 7,235,580 - Breslin , et al. June 26, 2 | 2007-06-26 |
Mitotic kinesin inhibitors App 20070129356 - Arrington; Kenneth L. ;   et al. | 2007-06-07 |
Mitotic kinesin inhibitors App 20070060601 - Arrington; Kenneth L. ;   et al. | 2007-03-15 |
Tyrosine kinase inhibitors Grant 7,186,723 - Peckham , et al. March 6, 2 | 2007-03-06 |
Tyrosine kinase inhibitors Grant 7,169,788 - Arrington , et al. January 30, 2 | 2007-01-30 |
Mitotic kinesin inhibitors App 20060234984 - Coleman; Paul J. ;   et al. | 2006-10-19 |
Tyrosine kinase inhibitors Grant 7,115,597 - Bilodeau , et al. October 3, 2 | 2006-10-03 |
Tyrosine kinase inhibitors Grant 7,109,204 - Fraley , et al. September 19, 2 | 2006-09-19 |
Benzazepinone alpha vintegrin receptor antagonists Grant 7,109,191 - Meissner , et al. September 19, 2 | 2006-09-19 |
Mitotic kinesin binding site App 20060134767 - Buser-Doepner; Carolyn A. ;   et al. | 2006-06-22 |
Prodrugs of mitotic kinesin inhibitors App 20060135594 - Fraley; Mark E. ;   et al. | 2006-06-22 |
Mitotic kinesin inhibitors App 20060105997 - Arrington; Kenneth L. ;   et al. | 2006-05-18 |
Mitotic kinesin inhibitors App 20060100191 - Breslin; MichaelJ ;   et al. | 2006-05-11 |
Tyrosine kinase inhibitors Grant 6,958,340 - Bilodeau , et al. October 25, 2 | 2005-10-25 |
Mitotic kinesin inhibitors App 20050234080 - Coleman, Paul J. ;   et al. | 2005-10-20 |
Mitotic kinesin inhibitors App 20050228003 - Fraley, Mark E ;   et al. | 2005-10-13 |
Mitotic kinesin inhibitors App 20050176737 - Fraley, Mark E ;   et al. | 2005-08-11 |
Tyrosine kinase inhibitors Grant 6,927,293 - Kim , et al. August 9, 2 | 2005-08-09 |
Mitotic kinesin inhibitors App 20050171122 - Fraley, Mark E. ;   et al. | 2005-08-04 |
Mitotic kinesin inhibitors App 20050119484 - Breslin, Michael J ;   et al. | 2005-06-02 |
Tyrosine kinase inhibitors App 20050096344 - Fraley, Mark E. ;   et al. | 2005-05-05 |
(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors Grant 6,875,767 - Bilodeau , et al. April 5, 2 | 2005-04-05 |
Mitotic kinesin inhibitors App 20050043357 - Coleman, Paul J. ;   et al. | 2005-02-24 |
Mitotic kinesin inhibitors App 20050038074 - Coleman, Paul J. ;   et al. | 2005-02-17 |
Mitotic kinesin inhibitors App 20050032817 - Fraley, Mark E ;   et al. | 2005-02-10 |
Tyrosine kinase inhibitors App 20040242637 - Hartman, George D ;   et al. | 2004-12-02 |
Tyrosine kinase inhibitors App 20040235875 - Fraley, Mark E. ;   et al. | 2004-11-25 |
Tyrosine kinase ihnibitors App 20040235826 - Peckham, Jennifer P. ;   et al. | 2004-11-25 |
Tyrosine kinase inhibitors App 20040235867 - Bilodeau, Mark T. ;   et al. | 2004-11-25 |
Tyrosine kinase inhibitors App 20040220201 - Bilodeau, Mark T. ;   et al. | 2004-11-04 |
Tyrosine kinase inhibitors App 20040220216 - Arrington, Kenneth L ;   et al. | 2004-11-04 |
Tyrosine kinase inhibitors App 20040192926 - Hartman, George D. ;   et al. | 2004-09-30 |
Tyrosine kinase inhibitors App 20040192725 - Kim, Yuntae ;   et al. | 2004-09-30 |
Tyrosine kinase inhibitors Grant 6,794,393 - Fraley , et al. September 21, 2 | 2004-09-21 |
Tyrosine kinase inhibitors App 20040181066 - Fraley, Mark E. ;   et al. | 2004-09-16 |
Integrin receptor antagonists Grant 6,784,190 - Askew , et al. August 31, 2 | 2004-08-31 |
Benzazepinone alpha vintegrin receptor antagonists App 20040142919 - Meissner, Robert S. ;   et al. | 2004-07-22 |
Combination therapy App 20040102360 - Barnett, Stanley F. ;   et al. | 2004-05-27 |
Tyrosine kinase inhibitors App 20040063720 - Bilodeau, Mark T. ;   et al. | 2004-04-01 |
Methods and compositions for treating peridontal disease App 20040053968 - Hartman, George D. ;   et al. | 2004-03-18 |
Tyrosine kinase inhibitors Grant 6,586,424 - Bilodeau , et al. July 1, 2 | 2003-07-01 |
Tyrosine kinase inhibitors Grant 6,586,423 - Bilodeau , et al. | 2003-07-01 |
Tyrosine kinase inhibitors App 20030100567 - Bilodeau, Mark T. ;   et al. | 2003-05-29 |
Tyrosine kinase inhibitors App 20030064996 - Bilodeau, Mark T. ;   et al. | 2003-04-03 |
Tyrosine kinase inhibitors App 20020147203 - Bilodeau, Mark T. ;   et al. | 2002-10-10 |
Tyrosine kinase inhibitors App 20020137755 - Bilodeau, Mark T. ;   et al. | 2002-09-26 |
Tyrosine kinase inhibitors Grant 6,420,382 - Fraley , et al. July 16, 2 | 2002-07-16 |
.alpha.v integrin receptor antagonists Grant 6,410,526 - Duggan , et al. June 25, 2 | 2002-06-25 |
Integrin receptor antagonists App 20020010176 - Askew, Ben C. ;   et al. | 2002-01-24 |
Tyrosine kinase inhibitors App 20010047007 - Fraley, Mark E. ;   et al. | 2001-11-29 |
Tyrosine kinase inhibitors App 20010044451 - Fraley, Mark E. ;   et al. | 2001-11-22 |
Tyrosine kinase inhibitors Grant 6,313,138 - Fraley , et al. November 6, 2 | 2001-11-06 |
Tyrosine kinase inhibitors Grant 6,306,874 - Fraley , et al. October 23, 2 | 2001-10-23 |
Integrin receptor antagonists Grant 6,297,249 - Duggan , et al. October 2, 2 | 2001-10-02 |
Integrin antagonists Grant 6,211,184 - Duggan , et al. April 3, 2 | 2001-04-03 |
Inhibitors of farnesyl-protein transferase Grant 6,066,738 - Dinsmore , et al. May 23, 2 | 2000-05-23 |
Integrin receptor antagonists Grant 6,048,861 - Askew , et al. April 11, 2 | 2000-04-11 |
Integrin receptor antagonists Grant 6,040,311 - Duggan , et al. March 21, 2 | 2000-03-21 |
Sulfonamide fibrinogen receptor antagonists Grant 6,040,317 - Duggan , et al. March 21, 2 | 2000-03-21 |
HMG-CoA reductase inhibitors Grant RE36,481 - Inamine , et al. January 4, 2 | 2000-01-04 |
Fibrinogen receptor antagonist prodrugs Grant 5,990,107 - Egbertson , et al. November 23, 1 | 1999-11-23 |
Integrin antagonists Grant 5,981,546 - Duggan , et al. November 9, 1 | 1999-11-09 |
Inhibitors of farnesyl-protein transferase Grant 5,968,965 - Dinsmore , et al. October 19, 1 | 1999-10-19 |
Integrin antagonists Grant 5,952,341 - Duggan , et al. September 14, 1 | 1999-09-14 |
Fibrinogen receptor antagonist prodrugs Grant 5,932,582 - Young , et al. August 3, 1 | 1999-08-03 |
Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption Grant 5,929,120 - Hartman , et al. July 27, 1 | 1999-07-27 |
.alpha..sub.v .beta..sub.3 antagonists Grant 5,925,655 - Duggan , et al. July 20, 1 | 1999-07-20 |
Sulfonamide fibrinogen receptor antagonists Grant 5,880,136 - Duggan , et al. March 9, 1 | 1999-03-09 |
Inhibitors of farnesyl-protein transferase Grant 5,856,326 - Anthony , et al. January 5, 1 | 1999-01-05 |
Fibrinogen receptor antagonists Grant 5,854,245 - Duggan , et al. December 29, 1 | 1998-12-29 |
Fibrinogen receptor antagonists Grant 5,852,045 - Askew , et al. December 22, 1 | 1998-12-22 |
Sulfonamide fibrinogen receptor antagonists Grant 5,814,643 - Duggan , et al. September 29, 1 | 1998-09-29 |
Fibrinogen receptor antagonists Grant 5,786,373 - Hartman , et al. July 28, 1 | 1998-07-28 |
Fibrinogen receptor antagonists Grant 5,780,480 - Wai , et al. July 14, 1 | 1998-07-14 |
Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption Grant 5,741,796 - Hartman , et al. April 21, 1 | 1998-04-21 |
Fibrinogen receptor antagonists Grant 5,719,144 - Hartman , et al. February 17, 1 | 1998-02-17 |
Fibrinogen receptor antagonists Grant 5,559,127 - Hartman , et al. September 24, 1 | 1996-09-24 |
Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets Grant 5,455,243 - Duggan , et al. October 3, 1 | 1995-10-03 |
Fibrinogen receptor antagonists Grant 5,416,099 - Hartman , et al. * May 16, 1 | 1995-05-16 |
Fibrinogen receptor antagonists Grant 5,397,791 - Hartman , et al. March 14, 1 | 1995-03-14 |
Fibrinogen receptor antagonists Grant 5,334,596 - Hartman , et al. August 2, 1 | 1994-08-02 |
Fibrinogen receptor antagonists Grant 5,294,616 - Duggan , et al. March 15, 1 | 1994-03-15 |
Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets Grant 5,281,585 - Duggan , et al. January 25, 1 | 1994-01-25 |
Fibrinogen receptor antagonists Grant 5,272,158 - Hartman , et al. December 21, 1 | 1993-12-21 |
Fibrinogen receptor antagonists Grant 5,264,420 - Duggan , et al. November 23, 1 | 1993-11-23 |
Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives Grant 5,217,994 - Egbertson , et al. June 8, 1 | 1993-06-08 |
Method of inhibiting osteoclast-mediated bone resorption by administration of N-heterocyclicalkyl-substituted phenyl derivatives Grant 5,204,350 - Egbertson , et al. April 20, 1 | 1993-04-20 |
5-Oxygenated HMG-COA reductase inhibitors Grant 5,130,306 - Duggan , et al. July 14, 1 | 1992-07-14 |
5-oxygenated HMG-CoA reductase inhibitors Grant 4,963,538 - Duggan , et al. October 16, 1 | 1990-10-16 |
Novel HMG-CoA reductase inhibitors Grant 4,940,727 - Inamine , et al. July 10, 1 | 1990-07-10 |
5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitors Grant 4,897,402 - Duggan , et al. January 30, 1 | 1990-01-30 |
Thiophene sulfonamide antiglaucoma agents Grant 4,847,289 - Baldwin , et al. July 11, 1 | 1989-07-11 |
Fused polycyclic and bridged compounds useful as calcium channel blockers Grant 4,808,718 - Hartman , et al. February 28, 1 | 1989-02-28 |
Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucoma agents Grant 4,806,562 - Hartman , et al. February 21, 1 | 1989-02-21 |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents Grant 4,751,231 - Halczenko , et al. June 14, 1 | 1988-06-14 |
Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers Grant 4,735,956 - Baldwin , et al. April 5, 1 | 1988-04-05 |
Substituted and bridged pyridines useful as calcium channel blockers Grant 4,599,341 - Halczenko , et al. July 8, 1 | 1986-07-08 |
Bridged pyridine compounds useful as calcium channel blockers and analgesics Grant 4,587,253 - Halczenko , et al. May 6, 1 | 1986-05-06 |
1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers Grant 4,548,941 - Halczenko , et al. October 22, 1 | 1985-10-22 |
N-Acyl derivatives of 6-alkylamino 5-chloro-3-nitropyrazinamines for radiation therapy Grant 4,414,215 - Hartman November 8, 1 | 1983-11-08 |
Process for preparation of 9-(dihalobenzyl)adenines Grant RE31,429 - Tull, deceased , et al. October 25, 1 | 1983-10-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.